Clinical Trials Logo

ADHD clinical trials

View clinical trials related to ADHD.

Filter by:

NCT ID: NCT05016102 Completed - Exercise Clinical Trials

Exercise Enhances Brain Function in Attention-deficit/Hyperactivity Disorder (ADHD)

Start date: August 23, 2013
Phase: N/A
Study type: Interventional

The aim of the study was to investigate the different effects of exercise types on inhibitory control in children with attention-deficit/ hyperactivity disorder.

NCT ID: NCT04999514 Completed - ADHD Clinical Trials

Examining the Effects of Parenting Interventions on Children With Attention-Deficit / Hyperactivity Disorder (AD/HD) and Their Parents

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

This study investigates the effects of parenting interventions on improving the emotion regulation and functioning of the children with AD/HD as well as their parents' parenting practices and psychological well-being. Two kinds of parenting interventions are selected in this study, namely the Mindful Parenting and Tuning in to Kids programs. The value of this project lies in empowering parents through parenting techniques which they can use both for themselves and for their daily interactions with children. It is hoped to alleviate their stress from the role of parenting children with special needs, which may in turn lead to their better psychological well-being and greater harmony in the families.

NCT ID: NCT04958460 Completed - ADHD Clinical Trials

Effect of Probiotics on ADHD

Start date: May 14, 2020
Phase: Phase 3
Study type: Interventional

Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder. Gut microbiome dysbiosis may be associated with the pathophysiology of ADHD. Investigators previously found the relative abundance of Sutterella stercoricanis were increased and Bifidobacterium bifidum were decreased in the ADHD group. Investigators hypothesize that ADHD patients receiving supplementary Bifidobacterium bifidum (Bf-688) is able to increase the proportion of Bf-688; inhibit the proportion of Sutterella; and improve ADHD symptoms.

NCT ID: NCT04946461 Completed - Adhd Clinical Trials

The Day-time Response Variation of (Lis)Dexamphetamine

IDEAL
Start date: July 1, 2021
Phase:
Study type: Observational

In the Netherlands, two forms of amphetamines are available for the treatment of ADHD in adults; dexamfetamine (Tentin) and lisdexamfetamine (Elvanse) and both belong to regular and primary care pharmacotherapy. Both drugs contain exactly the same substance dexamfetamine and it would be expected that the effects on the symptoms of ADHD and the duration of action should be comparable. Previous studies and daily practice have reported different effects and duration of action of both, however. In this study the investigators want to investigate this difference by giving both drugs to the same patient, objectify the blood concentrations, objective and subjective effects and hope to be able to further optimize the treatment for ADHD with amphetamines.

NCT ID: NCT04817059 Completed - Adhd Clinical Trials

Reducing Head Motion With Customized Head Mold in Young Children

Start date: June 19, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of a customized head mold for reducing head motion during MRI scanning in young children.

NCT ID: NCT04795674 Completed - ADHD Clinical Trials

Target ADHD Executive Working Memory Study

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

This study will assess whether or not a novel executive working memory training intervention for Attention-Deficit/Hyperactivity Disorder can engage frontoparietal brain network treatment targets and behavioral performance.

NCT ID: NCT04726813 Completed - ADHD Clinical Trials

An Internet-delivered Intervention for Coping With ADHD in Adulthood

MyADHD
Start date: April 27, 2021
Phase: N/A
Study type: Interventional

The primary aim of this study is to examine the efficacy of a self-guided Internet-delivered intervention for coping with ADHD. The secondary aim is to investigate the effects of individual adaptation of the intervention on adherence, satisfaction and clinical outcomes.

NCT ID: NCT04723719 Completed - Sleep Clinical Trials

Sleep IntervEntion as Symptom Treatment for ADHD

SIESTA
Start date: January 28, 2021
Phase: N/A
Study type: Interventional

Up to 72% of adolescents with ADHD portray sleep problems. The most common sleep difficulties in adolescents with ADHD are initial insomnia, nocturnal awakenings, non-restorative or restless sleep. These difficulties seem to be causally related to increased ADHD symptom impairment, oppositional and depressive symptomatology, and functional impairments in daily life, resulting in a vicious circle of sleep problems and impairment. Thus, reducing sleep problems is an important intervention target. However, to date there is no evidence-based cognitive behavioral sleep treatment available. Sleep-focused treatments need adaptation towards this developmental phase/disorder for effectiveness, as ADHD and sleep problems are bi-directional. Therefore, a blended treatment targeting the core deficits integrating motivational interviewing, planning skills and sleep interventions is needed. Thus, the aim of this project is testing the short and 3 months follow-up effectiveness of the blended CBT sleep intervention in adolescents with ADHD.

NCT ID: NCT04647903 Completed - ADHD Clinical Trials

Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR)

SEAL
Start date: October 5, 2020
Phase: Phase 1
Study type: Interventional

This is a randomized, double-blind, double-dummy, placebo- and active-controlled 4 period, 4 way crossover study to assess the intranasal abuse potential of manipulated ADAIR formulation in nondependent, recreational stimulant users. The study will consist of an outpatient Screening Visit, an in clinic Qualification Phase, an in-clinic Treatment Phase, and an outpatient Follow-Up visit.

NCT ID: NCT04636216 Completed - ADHD Clinical Trials

Open Trial of a Program to Support Parents of Children With Attention-deficit/Hyperactivity Disorder (ADHD)

Start date: November 3, 2020
Phase: N/A
Study type: Interventional

Behavioral parent training is an evidence-based treatment for ADHD. The intervention can be implemented individually, or in groups. Currently, group-based parent training programs require considerable coordination, including ascertainment of a large physical space, the coordination of all families traveling to the same location at the same time, and the require for the provision of childcare. Innovations in online connectivity and ease of implementation of online support applications (e.g., Zoom) may reduce these barriers. However, it is necessary to investigate the feasibility and promise of the online approach to ensure it supports parents effectively.